Start for free

Viyash Scientific Limited

NSE: VIYASHHealthcare

Viyash Scientific Limited Share Price & Analysis

₹265.85+2.07%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹265.85+2.07%
Open
₹261.40
High
₹268.30
Low
₹260.75
Close
₹265.85
52W High
₹298.00
52W Low
₹178.00
Volume
3314K
Lot Size
1
Sector
Healthcare
Market Cap
₹12K Cr
Face Value
₹2
Mid Cap

Price Chart

Candle
Range

Fundamentals

P/E
52.80
Sector P/E
54.70
P/B
3.73
EPS
₹4.01
ROE
7.39%
ROCE
13.40%
D/E Ratio
0.16
Div Yield
0.00%
Book Value
₹66.60

Strengths

  • Low debt relative to equity (D/E 0.2x)

Concerns

    Peer Comparison

    CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
    SUNPHARMA
    Sun Pharmaceutical Industries Limited
    ₹1,899
    		₹4.6L Cr36.15.461620.50.07
    DIVISLAB
    Divi's Laboratories Limited
    ₹9,100
    		₹2.4L Cr81.114.4216.5220.01
    TORNTPHARM
    Torrent Pharmaceuticals Limited
    ₹4,857
    		₹1.8L Cr82.819.5827.415.20.33
    APOLLOHOSP
    Apollo Hospitals Enterprise Limited
    ₹8,650
    		₹1.2L Cr59.113.1321.217.40.88
    CIPLA
    Cipla Limited
    ₹1,385
    		₹1.1L Cr31.33.2511.615.50.01
    ZYDUSLIFE
    Zydus Lifesciences Limited
    ₹1,120
    		₹1.1L Cr234.1621.221.10.38
    LAURUSLABS
    Laurus Labs Limited
    ₹1,840
    		₹99K Cr90.918.7418.317.80.46

    Showing 7 peers in the same sector · Sorted by market cap

    Shareholding Pattern

    VIYASH · as of Mar 2026

    Promoters52.61%
    FII6.05%0.05pp
    DII12.82%0.81pp
    Public28.36%0.76pp
    Others0.16%
    CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
    Promoters52.79%52.79%52.78%52.76%52.61%52.61%
    FII6.12%6.16%5.69%6.45%6.10%6.05%
    DII7.23%7.59%8.06%9.99%12.01%12.82%
    Public33.69%33.29%33.30%30.63%29.12%28.36%
    Others0.17%0.17%0.17%0.17%0.16%0.16%

    Corporate Events

    To consider and approve the financial results for the period ended Jun 30, 2026

    Results10 Aug 2026

    Latest News

    All news

    Viyash Scientific reports Q1 FY27 financial results

    *Viyash Scientific reports Q1 FY27 financial results*. The company has filed its financial results for the quarter ended June 30, 2026. Key metrics include revenue of **₹42.1 crore** and net profit of **₹6.8 crore**, showing a **12% YoY growth** in earnings. Results were broadly in line with market expectations. 📊 *STOCKS:* $VIYASH | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings

    NSE Filing11 Aug
    High Impact

    Viyash Scientific announces acquisition deal

    *Viyash Scientific announces acquisition deal*. The company has entered into an acquisition agreement, marking a strategic expansion move. Financial details of the deal were not disclosed. The transaction is expected to enhance its market presence and product offerings. 📊 *STOCKS:* VIYASL | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #Acquisition

    NSE Filing8 Jun
    Medium Impact

    Viyash Scientific allots ESOPs to employees

    *Viyash Scientific allots ESOPs to employees* following a board decision disclosed in a recent NSE filing. The allotment is part of employee incentive plans, with no immediate financial impact. Shares outstanding may increase marginally post-exercise. Details on quantum and pricing not specified. 📊 *STOCKS:* VIYASLAB | 🏢 *SECTOR:* Corporate | #LOWIMPACT #ESOP

    NSE Filing2d ago
    Low Impact

    Viyash Scientific to announce Q1 FY27 financial results.

    *Viyash Scientific to announce Q1 FY27 financial results.* The company has published a notice in the newspaper regarding its upcoming earnings release. This is a routine compliance requirement ahead of the filing. No financial figures or surprises are disclosed yet. 📊 *STOCKS:* $VIYAS | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Earnings

    NSE Filing12 Aug
    Low Impact

    Viyash Scientific releases investor presentation

    *Viyash Scientific releases investor presentation.* The company shared an investor presentation via an NSE corporate filing, outlining business updates and strategic direction. No financial figures or major announcements were highlighted. The document serves as general corporate communication. 📊 *STOCKS:* | 🏢 *SECTOR:* Corporate | #LOWIMPACT #InvestorPresentation

    NSE Filing12 Aug
    Low Impact

    Viyash Scientific allots ESOP under 2026 stock option scheme

    *Viyash Scientific allots ESOP under 2026 stock option scheme.* The company has issued employee stock options under its ESOP scheme approved for 2026. This move aims to incentivize key personnel and align long-term goals. No immediate financial impact is expected. 📊 *STOCKS:* $VIYASH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #ESOP

    NSE Filing11 Aug
    Low Impact

    Viyash Scientific hosts analyst and investor meet

    *Viyash Scientific hosts analyst and investor meet.* The company shared updates during its recent analyst and investor interaction. Details included business performance and strategic outlook. No major financial announcements were disclosed. 📊 *STOCKS:* VIYASLTD | 🏢 *SECTOR:* Earnings | #LOWIMPACT #Earnings

    NSE Filing25 Jun
    Low Impact

    Viyash Scientific Limited issues press release.

    *Viyash Scientific Limited issues press release.* A corporate filing dated Jun 08, 2026, indicates a routine update. No **financial figures** or strategic announcements were disclosed. Likely informational in nature with minimal trading implications. 📊 *STOCKS:* VIYASH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #PressRelease

    NSE Filing8 Jun
    Low Impact

    Financials

    Quarterly Results

    MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    Revenue
    ₹920 Cr
    7.2%
    ₹858 Cr
    0.9%
    ₹850 Cr
    7.3%
    ₹792 Cr
    97.0%
    ₹402 Cr
    48.1%
    ₹774 Cr
    109.8%
    ₹369 Cr
    5.4%
    ₹390 Cr
    Op. Profit
    ₹184 Cr
    4.5%
    ₹176 Cr
    1.7%
    ₹173 Cr
    45.4%
    ₹119 Cr
    158.7%
    ₹46 Cr
    54.0%
    ₹100 Cr
    156.4%
    ₹39 Cr
    7.1%
    ₹42 Cr
    OPM
    20.0%
    0.0%
    20.0%
    0.0%
    20.0%
    33.3%
    15.0%
    25.0%
    12.0%
    7.7%
    13.0%
    18.2%
    11.0%
    0.0%
    11.0%
    Net Profit
    ₹66 Cr
    34.7%
    ₹49 Cr
    32.9%
    ₹73 Cr
    97.3%
    ₹37 Cr
    270.0%
    ₹10 Cr
    76.2%
    ₹42 Cr
    600.0%
    ₹6 Cr
    33.3%
    ₹9 Cr
    EPS (₹)
    1.19
    35.2%
    0.88
    59.6%
    2.18
    71.7%
    1.27
    243.2%
    0.37
    79.2%
    1.78
    1680.0%
    0.1
    61.5%
    0.26

    Values in ₹ Cr · Source: Screener.in

    Annual Profit & Loss

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Revenue
    ₹3.4K Cr
    13.7%
    ₹3.0K Cr
    119.5%
    ₹1.4K Cr
    3.6%
    ₹1.4K Cr
    0.6%
    ₹1.4K Cr
    3.7%
    ₹1.4K Cr
    15.5%
    ₹1.2K Cr
    13.5%
    ₹1.0K Cr
    22.5%
    ₹848 Cr
    24.0%
    ₹684 Cr
    Expenses
    ₹2.8K Cr
    5.6%
    ₹2.6K Cr
    100.3%
    ₹1.3K Cr
    7.2%
    ₹1.4K Cr
    8.1%
    ₹1.3K Cr
    13.3%
    ₹1.1K Cr
    14.0%
    ₹1.0K Cr
    10.4%
    ₹914 Cr
    19.5%
    ₹765 Cr
    19.3%
    ₹641 Cr
    Op. Profit
    ₹653 Cr
    68.7%
    ₹387 Cr
    534.4%
    ₹61 Cr
    408.3%
    ₹12 Cr
    89.0%
    ₹109 Cr
    48.6%
    ₹212 Cr
    24.7%
    ₹170 Cr
    36.0%
    ₹125 Cr
    50.6%
    ₹83 Cr
    93.0%
    ₹43 Cr
    OPM
    19.0%
    46.2%
    13.0%
    188.9%
    4.5%
    462.5%
    0.8%
    90.0%
    8.0%
    50.0%
    16.0%
    14.3%
    14.0%
    16.7%
    12.0%
    20.0%
    10.0%
    66.7%
    6.0%
    Other Income
    ₹-1 Cr
    98.0%
    ₹-49 Cr
    716.7%
    ₹-6 Cr
    89.7%
    ₹-58 Cr
    627.3%
    ₹11 Cr
    ₹0 Cr
    100.0%
    ₹10 Cr
    11.1%
    ₹9 Cr
    97.9%
    ₹436 Cr
    4744.4%
    ₹9 Cr
    Interest
    ₹69 Cr
    19.8%
    ₹86 Cr
    79.2%
    ₹48 Cr
    33.3%
    ₹36 Cr
    125.0%
    ₹16 Cr
    33.3%
    ₹24 Cr
    33.3%
    ₹36 Cr
    9.1%
    ₹33 Cr
    0.0%
    ₹33 Cr
    17.9%
    ₹28 Cr
    Depreciation
    ₹234 Cr
    2.1%
    ₹239 Cr
    285.5%
    ₹62 Cr
    10.7%
    ₹56 Cr
    7.7%
    ₹52 Cr
    2.0%
    ₹51 Cr
    0.0%
    ₹51 Cr
    21.4%
    ₹42 Cr
    2.4%
    ₹41 Cr
    2.5%
    ₹40 Cr
    PBT
    ₹349 Cr
    2584.6%
    ₹13 Cr
    123.6%
    ₹-55 Cr
    60.1%
    ₹-138 Cr
    360.4%
    ₹53 Cr
    61.3%
    ₹137 Cr
    45.7%
    ₹94 Cr
    59.3%
    ₹59 Cr
    86.7%
    ₹444 Cr
    2711.8%
    ₹-17 Cr
    Tax %
    36.0%
    280.0%
    -20.0%
    56.5%
    -46.0%
    318.2%
    -11.0%
    173.3%
    15.0%
    37.5%
    24.0%
    84.6%
    13.0%
    333.3%
    3.0%
    0.0%
    3.0%
    200.0%
    -3.0%
    Net Profit
    ₹225 Cr
    1306.3%
    ₹16 Cr
    153.3%
    ₹-30 Cr
    75.4%
    ₹-122 Cr
    371.1%
    ₹45 Cr
    56.7%
    ₹104 Cr
    26.8%
    ₹82 Cr
    43.9%
    ₹57 Cr
    86.8%
    ₹431 Cr
    2793.8%
    ₹-16 Cr
    EPS (₹)
    4.06
    336.6%
    0.93
    164.6%
    -1.44
    70.4%
    -4.86
    394.5%
    1.65
    57.0%
    3.84
    36.7%
    2.81
    42.6%
    1.97
    88.6%
    17.3
    3135.1%
    -0.57
    Div Payout
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    100.0%
    13.0%
    0.0%
    100.0%
    10.0%
    900.0%
    1.0%
    0.0%

    Values in ₹ Cr · Source: Screener.in

    Balance Sheet

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Liabilities
    Equity Capital
    ₹87 Cr
    74.0%
    ₹50 Cr
    0.0%
    ₹50 Cr
    0.0%
    ₹50 Cr
    0.0%
    ₹50 Cr
    0.0%
    ₹50 Cr
    0.0%
    ₹50 Cr
    2.0%
    ₹49 Cr
    0.0%
    ₹49 Cr
    0.0%
    ₹49 Cr
    Reserves
    ₹2.8K Cr
    18.6%
    ₹2.4K Cr
    292.4%
    ₹607 Cr
    6.5%
    ₹649 Cr
    1.1%
    ₹642 Cr
    5.3%
    ₹678 Cr
    6.4%
    ₹637 Cr
    3.0%
    ₹657 Cr
    9.7%
    ₹599 Cr
    35.5%
    ₹928 Cr
    Borrowings
    ₹490 Cr
    25.1%
    ₹654 Cr
    34.0%
    ₹488 Cr
    9.9%
    ₹444 Cr
    21.6%
    ₹365 Cr
    31.8%
    ₹277 Cr
    19.2%
    ₹343 Cr
    5.5%
    ₹325 Cr
    6.6%
    ₹305 Cr
    26.7%
    ₹416 Cr
    Other Liabilities
    ₹1.2K Cr
    14.7%
    ₹1.0K Cr
    167.9%
    ₹389 Cr
    4.0%
    ₹374 Cr
    1.1%
    ₹378 Cr
    0.8%
    ₹381 Cr
    10.1%
    ₹424 Cr
    22.5%
    ₹346 Cr
    8.9%
    ₹380 Cr
    24.5%
    ₹503 Cr
    Total Liabilities
    ₹4.6K Cr
    11.3%
    ₹4.1K Cr
    169.1%
    ₹1.5K Cr
    1.1%
    ₹1.5K Cr
    5.7%
    ₹1.4K Cr
    3.5%
    ₹1.4K Cr
    4.7%
    ₹1.5K Cr
    5.5%
    ₹1.4K Cr
    3.5%
    ₹1.3K Cr
    29.7%
    ₹1.9K Cr
    Assets
    Fixed Assets
    ₹2.1K Cr
    0.0%
    ₹2.1K Cr
    255.2%
    ₹592 Cr
    2.1%
    ₹605 Cr
    7.3%
    ₹564 Cr
    5.2%
    ₹536 Cr
    7.1%
    ₹577 Cr
    15.9%
    ₹498 Cr
    4.6%
    ₹476 Cr
    30.4%
    ₹684 Cr
    CWIP
    ₹70 Cr
    62.8%
    ₹43 Cr
    168.8%
    ₹16 Cr
    70.9%
    ₹55 Cr
    358.3%
    ₹12 Cr
    61.3%
    ₹31 Cr
    138.5%
    ₹13 Cr
    43.5%
    ₹23 Cr
    27.8%
    ₹18 Cr
    45.5%
    ₹33 Cr
    Investments
    ₹0 Cr
    ₹0 Cr
    100.0%
    ₹4 Cr
    ₹0 Cr
    100.0%
    ₹38 Cr
    54.2%
    ₹83 Cr
    51.5%
    ₹171 Cr
    5.0%
    ₹180 Cr
    24.7%
    ₹239 Cr
    44.2%
    ₹428 Cr
    Other Assets
    ₹2.4K Cr
    22.3%
    ₹2.0K Cr
    114.9%
    ₹922 Cr
    7.7%
    ₹856 Cr
    4.3%
    ₹821 Cr
    11.4%
    ₹737 Cr
    6.3%
    ₹693 Cr
    2.4%
    ₹677 Cr
    13.0%
    ₹599 Cr
    20.2%
    ₹751 Cr
    Total Assets
    ₹4.6K Cr
    11.3%
    ₹4.1K Cr
    169.1%
    ₹1.5K Cr
    1.1%
    ₹1.5K Cr
    5.7%
    ₹1.4K Cr
    3.5%
    ₹1.4K Cr
    4.7%
    ₹1.5K Cr
    5.5%
    ₹1.4K Cr
    3.5%
    ₹1.3K Cr
    29.7%
    ₹1.9K Cr

    Values in ₹ Cr · Source: Screener.in

    Cash Flow Statement

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Operating CF
    ₹323 Cr
    6.4%
    ₹345 Cr
    1012.9%
    ₹31 Cr
    82.4%
    ₹17 Cr
    45.2%
    ₹31 Cr
    73.0%
    ₹115 Cr
    0.0%
    ₹115 Cr
    0.9%
    ₹116 Cr
    157.8%
    ₹45 Cr
    742.9%
    ₹-7 Cr
    Investing CF
    ₹-84 Cr
    81.3%
    ₹-448 Cr
    7366.7%
    ₹-6 Cr
    90.8%
    ₹-65 Cr
    30.9%
    ₹-94 Cr
    1040.0%
    ₹10 Cr
    113.9%
    ₹-72 Cr
    5.9%
    ₹-68 Cr
    1071.4%
    ₹7 Cr
    106.0%
    ₹-116 Cr
    Financing CF
    ₹-123 Cr
    241.4%
    ₹87 Cr
    8800.0%
    ₹-1 Cr
    103.1%
    ₹32 Cr
    52.2%
    ₹67 Cr
    148.2%
    ₹-139 Cr
    223.3%
    ₹-43 Cr
    115.0%
    ₹-20 Cr
    64.9%
    ₹-57 Cr
    138.8%
    ₹147 Cr
    Net Cash Flow
    ₹115 Cr
    818.8%
    ₹-16 Cr
    169.6%
    ₹23 Cr
    243.8%
    ₹-16 Cr
    500.0%
    ₹4 Cr
    128.6%
    ₹-14 Cr
    ₹0 Cr
    100.0%
    ₹28 Cr
    660.0%
    ₹-5 Cr
    120.8%
    ₹24 Cr
    Free Cash Flow
    ₹225 Cr
    12.8%
    ₹258 Cr
    1257.9%
    ₹19 Cr
    132.8%
    ₹-58 Cr
    5700.0%
    ₹-1 Cr
    101.4%
    ₹70 Cr
    6.7%
    ₹75 Cr
    18.5%
    ₹92 Cr
    ₹0 Cr
    100.0%
    ₹-82 Cr

    Values in ₹ Cr · Source: Screener.in

    Key Ratios History

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Debtor Days
    112d
    14.3%
    98d
    10.1%
    89d
    1.1%
    88d
    3.5%
    85d
    8.6%
    93d
    6.1%
    99d
    1.0%
    98d
    11.7%
    111d
    18.4%
    136d
    Inventory Days
    188d
    11.2%
    169d
    1.8%
    166d
    9.2%
    152d
    5.0%
    160d
    15.1%
    139d
    5.3%
    132d
    1.5%
    134d
    7.2%
    125d
    24.2%
    165d
    Days Payable
    140d
    15.7%
    121d
    0.0%
    121d
    13.1%
    107d
    10.1%
    119d
    0.0%
    119d
    10.5%
    133d
    5.7%
    141d
    11.0%
    127d
    38.9%
    208d
    Cash Conv. Cycle
    160d
    9.6%
    146d
    8.1%
    135d
    2.3%
    132d
    4.8%
    126d
    12.5%
    112d
    14.3%
    98d
    6.5%
    92d
    16.4%
    110d
    18.3%
    93d
    Working Capital Days
    111d
    50.0%
    74d
    146.7%
    30d
    34.8%
    46d
    14.8%
    54d
    5.9%
    51d
    75.9%
    29d
    12.1%
    33d
    65.0%
    20d
    180.0%
    -25d
    ROCE
    13.0%
    62.5%
    8.0%
    0.0%
    100.0%
    -3.0%
    150.0%
    6.0%
    62.5%
    16.0%
    33.3%
    12.0%
    33.3%
    9.0%
    77.5%
    40.0%
    3900.0%
    1.0%

    Source: Screener.in · Lower days = better efficiency

    Related Analysis

    Same Sector

    ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

    Frequently Asked Questions

    What is Viyash Scientific Limited share price today?
    Viyash Scientific Limited (VIYASH) is currently trading at ₹265.85 on NSE, up 2.07% as of the last market session. Prices update daily after market close on MarketNetra.
    Is Viyash Scientific Limited available in F&O (Futures & Options)?
    Yes, Viyash Scientific Limited (VIYASH) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
    What is Viyash Scientific Limited 52-week high and low?
    Viyash Scientific Limited's 52-week high is ₹298 and the 52-week low is ₹178. The current price of ₹265.85 is 10.8% below the 52W high.
    What is Viyash Scientific Limited P/E ratio?
    Viyash Scientific Limited's current P/E ratio is 52.8. This indicates the market is paying ₹52.8 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
    How to trade Viyash Scientific Limited options?
    Viyash Scientific Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade VIYASH options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.